ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc (0HD2)

100.80
0.00
(0.00%)
Closed April 27 10:30AM

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 89.91M74.91M219.75M492.85M844.29M1.04B1.83B2.25B
Operating Income -500.09M-814.67M-939.43M-828.44M-708.65M-785.07M-282.18M-176.89M
Pre Tax Income -490.87M-760.67M-885.25M-855.6M-852.14M-1.13B-433.52M-377.38M
Net Income -490.87M-761.5M-886.12M-858.28M-852.82M-1.13B-440.24M-278.16M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -4.925-7.526-7.898-7.372-7.096-9.128-3.508-2.157
EBIT -503.11M-789.94M-918.7M-782.91M-727.96M-791.28M-407.86M-183.72M
EBITDA -488.19M-801.87M-922.83M-798.24M-661.09M-740.6M-228.12M-120.22M